Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | Addiction | Research

Antibiotic therapy completion for injection drug use-associated infective endocarditis at a center with routine addiction medicine consultation: a retrospective cohort study

Authors: Muhammad Dhanani, Courtney Goodrich, Janice Weinberg, Carlos Acuna-Villaorduna, Tamar F. Barlam

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Background

Addiction medicine consultation and medications for opioid use disorder are shown to improve outcomes for patients hospitalized with infective endocarditis associated with injection drug use. Existing studies describe settings where addiction medicine consultation and initiation of medications for opioid use disorder are not commonplace, and rates of antibiotic therapy completion are infrequently reported. This retrospective study sought to quantify antibiotic completion outcomes in a setting where these interventions are routinely implemented.

Methods

Medical records of patients hospitalized with a diagnosis of bacteremia or infective endocarditis at an urban hospital between October 1, 2015 and December 31, 2017 were screened for active injection drug use within 6 months of hospitalization and infective endocarditis. Demographic and clinical parameters, receipt of antibiotics and medications for opioid use disorder, and details of re-hospitalizations within 1 year of discharge were recorded.

Results

Of 567 subjects screened for inclusion, 47 had infective endocarditis and active injection drug use. Addiction medicine consultation was completed for 41 patients (87.2%) and 23 (48.9%) received medications for opioid use disorder for the entire index admission. Forty-three patients (91.5%) survived to discharge, of which 28 (59.6%) completed antibiotic therapy. Twenty-nine survivors (67.4%) were re-hospitalized within 1 year due to infectious complications of injection drug use.

Conclusions

Among patients admitted to a center with routine addiction medicine consultation and initiation of medications for opioid use disorder, early truncation of antibiotic therapy and re-hospitalization were commonly observed.
Appendix
Available only for authorised users
Literature
1.
go back to reference Center for Behavioral Health Statistics and Quality. 2017 National Survey on Drug Use and Health: Detailed Tables. Substance Abuse and Mental Health Services Administration, Rockville, MD. 2018. Center for Behavioral Health Statistics and Quality. 2017 National Survey on Drug Use and Health: Detailed Tables. Substance Abuse and Mental Health Services Administration, Rockville, MD. 2018.
2.
go back to reference Fleischaeur AT, Ruhl L, Rhea S, Barnes E. Hospitalizations for endocarditis and associated health care costs among persons with diagnosed drug dependence – North Carolina, 2010–2015. MMWR. 2017;66(22):569–73. Fleischaeur AT, Ruhl L, Rhea S, Barnes E. Hospitalizations for endocarditis and associated health care costs among persons with diagnosed drug dependence – North Carolina, 2010–2015. MMWR. 2017;66(22):569–73.
3.
go back to reference Ronan MV, Herzig SJ. Hospitalizations related to opioid abuse/dependence and associated serious infections increased sharply, 2002–12. Health Aff (Millwood). 2016;35(5):832–7.CrossRef Ronan MV, Herzig SJ. Hospitalizations related to opioid abuse/dependence and associated serious infections increased sharply, 2002–12. Health Aff (Millwood). 2016;35(5):832–7.CrossRef
4.
go back to reference Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths—United States, 2013–2017. MMWR. 2018;67(5152):1419–27.PubMedPubMedCentral Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths—United States, 2013–2017. MMWR. 2018;67(5152):1419–27.PubMedPubMedCentral
5.
go back to reference Marks LR, Munigala S, Warren DK, Liang SY, Schwarz ES, Durkin MJ. Addiction medicine consultations reduce readmission rates for patients with serious infections from opioid use disorder. Clin Infect Dis. 2019;68(11):1935–7.CrossRef Marks LR, Munigala S, Warren DK, Liang SY, Schwarz ES, Durkin MJ. Addiction medicine consultations reduce readmission rates for patients with serious infections from opioid use disorder. Clin Infect Dis. 2019;68(11):1935–7.CrossRef
6.
go back to reference Trowbridge P, Weinstein ZM, Kerensky T, Roy P, Regan D, Samet JH, Walley AY. Addiction consultation services—linking hospitalized patients to outpatient addiction treatment. J Subst Abuse Treat. 2017;79:1–5.CrossRef Trowbridge P, Weinstein ZM, Kerensky T, Roy P, Regan D, Samet JH, Walley AY. Addiction consultation services—linking hospitalized patients to outpatient addiction treatment. J Subst Abuse Treat. 2017;79:1–5.CrossRef
7.
go back to reference Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633–8.CrossRef Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633–8.CrossRef
8.
go back to reference Barocas JA, Morgan JR, Wang J, McLoone D, Wurcel A, Stein MD. Outcomes associated with medications for opioid use disorder among persons hospitalized for infective endocarditis. Clin Infect Dis. 2021;72(3):472–8.CrossRef Barocas JA, Morgan JR, Wang J, McLoone D, Wurcel A, Stein MD. Outcomes associated with medications for opioid use disorder among persons hospitalized for infective endocarditis. Clin Infect Dis. 2021;72(3):472–8.CrossRef
9.
go back to reference Suzuki J, Johnson JA, Montgomery MW, Hayden MC, Price CN, Solomon DA, Liebschutz JM, Schnipper JL, Weiss RD. Long-term outcomes of injection drug-related infective endocarditis among people who inject drugs. J Addict Med. 2020;14(4):282–6.CrossRef Suzuki J, Johnson JA, Montgomery MW, Hayden MC, Price CN, Solomon DA, Liebschutz JM, Schnipper JL, Weiss RD. Long-term outcomes of injection drug-related infective endocarditis among people who inject drugs. J Addict Med. 2020;14(4):282–6.CrossRef
10.
go back to reference Kimmel SD, Del Rio C. Improving outcomes for people with injection drug-related endocarditis: are medications for opioid use disorder enough? J Addict Med. 2019;14(4):280–1.CrossRef Kimmel SD, Del Rio C. Improving outcomes for people with injection drug-related endocarditis: are medications for opioid use disorder enough? J Addict Med. 2019;14(4):280–1.CrossRef
11.
go back to reference Pytell JD, Sharfstein JM, Olsen Y. Facilitating methadone use in hospitals and skilled nursing facilities. JAMA Intern Med. 2020;180(1):7–8.CrossRef Pytell JD, Sharfstein JM, Olsen Y. Facilitating methadone use in hospitals and skilled nursing facilities. JAMA Intern Med. 2020;180(1):7–8.CrossRef
12.
go back to reference Fanucchi LC, Walsch SL, Thornton AC, Nuzzo PA, Lofwall MR. Outpatient parenteral antimicrobial therapy plus buprenorphine for opioid use disorder and severe injection-related infections. Clin Infect Dis. 2020;70(6):1226–9.CrossRef Fanucchi LC, Walsch SL, Thornton AC, Nuzzo PA, Lofwall MR. Outpatient parenteral antimicrobial therapy plus buprenorphine for opioid use disorder and severe injection-related infections. Clin Infect Dis. 2020;70(6):1226–9.CrossRef
13.
go back to reference Hawkins EJ, Danner AN, Malte CA, Painter JM, Lott AMK, Baer JS. Feasibility of a care management approach for complex substance use disorders and high acute services utilization. J Subst Abuse Treat. 2018;92:100–8.CrossRef Hawkins EJ, Danner AN, Malte CA, Painter JM, Lott AMK, Baer JS. Feasibility of a care management approach for complex substance use disorders and high acute services utilization. J Subst Abuse Treat. 2018;92:100–8.CrossRef
14.
go back to reference McGrew KM, Homco JB, Garwe T, Dao HD, Williams MB, Drevets DA, Jafarzadeh SR, Zhao YD, Carabin H. Validity of International Classification of Diseases codes in identifying illicit drug use target conditions using medical record data as a reference standard: a systematic review. Drug Alcohol Dep. 2020;208:107825.CrossRef McGrew KM, Homco JB, Garwe T, Dao HD, Williams MB, Drevets DA, Jafarzadeh SR, Zhao YD, Carabin H. Validity of International Classification of Diseases codes in identifying illicit drug use target conditions using medical record data as a reference standard: a systematic review. Drug Alcohol Dep. 2020;208:107825.CrossRef
15.
go back to reference Miller AC, Polgreen PM. Many opportunities to record, diagnose, or treat injection drug-related infections are missed: a population-based cohort study of inpatients and emergency department settings. Clin Infect Dis. 2019;68(7):1166–75.CrossRef Miller AC, Polgreen PM. Many opportunities to record, diagnose, or treat injection drug-related infections are missed: a population-based cohort study of inpatients and emergency department settings. Clin Infect Dis. 2019;68(7):1166–75.CrossRef
16.
go back to reference Zoorob M. Fentanyl shock: the changing geography of overdose in the United States. Int J Drug Policy. 2019;70:40–6.CrossRef Zoorob M. Fentanyl shock: the changing geography of overdose in the United States. Int J Drug Policy. 2019;70:40–6.CrossRef
Metadata
Title
Antibiotic therapy completion for injection drug use-associated infective endocarditis at a center with routine addiction medicine consultation: a retrospective cohort study
Authors
Muhammad Dhanani
Courtney Goodrich
Janice Weinberg
Carlos Acuna-Villaorduna
Tamar F. Barlam
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07122-x

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.